Published in Prog Cardiovasc Dis on June 20, 1974
Effect of intravenous adrenaline on electrocardiogram, blood pressure, and serum potassium. Br Heart J (1983) 1.79
Evaluation of children with ventricular arrhythmias. Arch Dis Child (1977) 1.48
Consistent linkage of the long-QT syndrome to the Harvey ras-1 locus on chromosome 11. Am J Hum Genet (1991) 1.15
Electrocardiogram analysis in adult patients with sickle cell disease. J Natl Med Assoc (1987) 0.88
Evidence of a long QT founder gene with varying phenotypic expression in South African families. J Med Genet (1996) 0.86
Prolapsing mitral valve leaflet syndrome. West J Med (1975) 0.83
Investigation of QT interval in adult coeliac disease. BMJ (1992) 0.79
Giant negative T waves after maxillofacial surgery. Anesth Prog (1992) 0.76
PITUITARY TUMOR, QT PROLONGATION AND VENTRICULAR ARRHYTHMIA. Cardiovasc Dis (1978) 0.75
Molecular genetic aspects of the Romano-Ward long QT syndrome. Tex Heart Inst J (1994) 0.75
Ischemic electrocardiographic pattern secondary to gallbladder disease: Evaluation of possible mechanisms. Cardiovasc Dis (1981) 0.75
Cardiac arrhythmias and epilepsy. Br Med J (1977) 0.75
A case of the cardio-auditory syndrome (long QT interval and profound deafness) diagnosed in the perinatal period and kept under surveillance for two years. Ulster Med J (1978) 0.75
A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell (1995) 10.18
Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation (2000) 7.50
Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation (2001) 7.47
Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet (1996) 7.35
Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation (2000) 5.09
Diagnostic criteria for the long QT syndrome. An update. Circulation (1993) 4.48
The long QT syndrome. Prospective longitudinal study of 328 families. Circulation (1991) 3.99
ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation (1995) 3.79
Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med (1998) 3.41
Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene. Science (1991) 3.38
Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation (2000) 2.95
Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. The SADS Foundation Task Force on LQTS. Circulation (1996) 2.70
Molecular basis of the long-QT syndrome associated with deafness. N Engl J Med (1997) 2.57
Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation (1998) 2.53
Functional distribution of right and left stellate innervation to the ventricles. Production of neurogenic electrocardiographic changes by unilateral alteration of sympathetic tone. Circ Res (1966) 2.47
Cardiac sodium channel mutations in patients with long QT syndrome, an inherited cardiac arrhythmia. Hum Mol Genet (1995) 2.30
Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler Thromb Vasc Biol (1996) 1.94
Genomic structure of three long QT syndrome genes: KVLQT1, HERG, and KCNE1. Genomics (1998) 1.93
Coronary spasm producing coronary thrombosis and myocardial infarction. N Engl J Med (1983) 1.91
Two long QT syndrome loci map to chromosomes 3 and 7 with evidence for further heterogeneity. Nat Genet (1994) 1.55
Hypothesis for the molecular physiology of the Romano-Ward long QT syndrome. J Am Coll Cardiol (1992) 1.55
Adrenergic effects of the QT interval of the electrocardiogram. Am Heart J (1976) 1.54
New mutations in the KVLQT1 potassium channel that cause long-QT syndrome. Circulation (1998) 1.53
Electrophysiological modeling of fibroblasts and their interaction with myocytes. Ann Biomed Eng (2007) 1.42
Redundancy reduction for improved display and analysis of body surface potential maps. I. Spatial compression. Circ Res (1981) 1.26
Liver enzyme monitoring in patients treated with troglitazone. JAMA (2001) 1.26
Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome. Am J Cardiol (1999) 1.25
Plasma homocyst(e)ine as a risk factor for early familial coronary artery disease. Clin Chem (1994) 1.24
Limited lead selection for estimation of body surface potential maps in electrocardiography. IEEE Trans Biomed Eng (1978) 1.23
Influence of sympathetic tone on ventricular fibrillation threshold during experimental coronary occlusion. Am J Cardiol (1975) 1.23
Relation of ventricular repolarization to electrocardiographic T wave-form and arrhythmia vulnerability. Am J Physiol (1979) 1.18
KCNQ1 mutations in patients with a family history of lethal cardiac arrhythmias and sudden death. Clin Genet (2003) 1.16
Consistent linkage of the long-QT syndrome to the Harvey ras-1 locus on chromosome 11. Am J Hum Genet (1991) 1.15
The sequence of normal ventricular recovery. Am Heart J (1972) 1.10
A model of electrical conduction in cardiac tissue including fibroblasts. Ann Biomed Eng (2009) 1.08
Local ventricular repolarization changes due to sympathetic nerve-branch stimulation. Am J Physiol (1975) 1.05
Notched T waves in young persons with central nervous system lesions. Circulation (1968) 1.05
Lipoprotein(a) interactions with lipid and nonlipid risk factors in early familial coronary artery disease. Arterioscler Thromb Vasc Biol (1997) 1.05
Age-gender influence on the rate-corrected QT interval and the QT-heart rate relation in families with genotypically characterized long QT syndrome. J Am Coll Cardiol (1997) 1.01
Role of DNA testing for diagnosis, management, and genetic screening in long QT syndrome, hypertrophic cardiomyopathy, and Marfan syndrome. Heart (2001) 0.99
Redundancy reduction for improved display and analysis of body surface potential maps. II. Temporal compression. Circ Res (1981) 0.99
Computer simulations of three-dimensional propagation in ventricular myocardium. Effects of intramural fiber rotation and inhomogeneous conductivity on epicardial activation. Circ Res (1993) 0.99
Comparative dependence on adrenergic neural tone by automaticity in the sinus node and in the atrioventricular junction. J Pharmacol Exp Ther (1973) 0.98
Dependence of intraventricular pressures on activation order before and after experimental Purkinje net block. J Electrocardiol (1970) 0.95
The electrocardiographic recognition of cardiac states at high risk of ventricular arrhythmias. An experimental study in dogs. Circ Res (1978) 0.93
Clinically practical lead systems for improved electrocardiography: comparison with precordial grids and conventional lead systems. Circulation (1979) 0.92
Clinical implications for affected parents and siblings of probands with long-QT syndrome. Circulation (2001) 0.92
Clinical and genetic variables associated with acute arousal and nonarousal-related cardiac events among subjects with long QT syndrome. Am J Cardiol (2000) 0.92
Time course of vulnerability to fibrillation after experimental coronary occlusion. Am J Cardiol (1971) 0.89
The sequence of normal recovery of excitability in the dog heart. Circulation (1975) 0.88
The electrocardiogram and the central nervous system. Prog Cardiovasc Dis (1970) 0.88
Ventricular recovery properties and QRST deflection area in cardiac electrograms. Am J Physiol (1980) 0.87
The financial impact of Medicare diagnosis-related groups. Effect upon hospitals receiving cardiac patients referred for tertiary care. Chest (1987) 0.87
Relation of variations in activation order to intraventricular pressures during premature beats. Circ Res (1966) 0.87
Cardiac effects of stimulation and block of the stellate ganglion. Anesthesiology (1973) 0.86
Cancellation of electrocardiographic effects during ventricular recovery. J Electrocardiol (1969) 0.86
Clinical applications of body surface potential mapping. Clin Cardiol (1995) 0.86
Higher plasma homocyst(e)ine and increased susceptibility to adverse effects of low folate in early familial coronary artery disease. Arterioscler Thromb Vasc Biol (1995) 0.85
Atrial fibrillation. Am J Cardiol (1971) 0.85
Analysis of HLA and disease susceptibility: chromosome 6 genes and sex influence long-QT phenotype. Am J Hum Genet (1994) 0.84
Locus heterogeneity of autosomal dominant long QT syndrome. J Clin Invest (1993) 0.84
Contributions of the specialized conduction system to the activation sequence in the canine pulmonary conus. Am J Physiol (1997) 0.84
Long QT syndrome in children: the value of rate corrected QT interval and DNA analysis as screening tests in the general population. J Med Screen (2001) 0.83
Electrotonic interaction during canine ventricular repolarization. Circ Res (1978) 0.83
Accelerated repolarization as a factor in re-entry--stimulation of the electrophysiology of acute myocardial infarction. Am Heart J (1974) 0.83
Sequences of early and late phases of repolarization on dog ventricular epicardium. J Electrocardiol (1981) 0.82
Reversible segmental myocardial dysfunction in septic shock. Crit Care Med (1986) 0.82
Analysis of T-wave abnormalities associated with myocardial infarction using a theoretic model. Circulation (1968) 0.82
Fibrillation threshold of a patient with myocardial infarction treated with a fixed-rate pacemaker: case report. Am Heart J (1970) 0.81
Effects of bilateral and unilateral stellate stimulation on canine ventricular refractory periods at sites overlapping innervation. Circ Res (1978) 0.81
Mechanisms of ischemic ST-segment displacement. Evaluation by direct current recordings. Circulation (1977) 0.81
Effects of age, sex, and body habitus on QRS and ST-T potential maps of 1100 normal subjects. Circulation (1985) 0.81
A theoretic model of the T wave. Circulation (1966) 0.80
Effects of acute hyperkalemia on cardiac excitability. Am Heart J (1977) 0.80
The prolonged QT interval. Annu Rev Med (1979) 0.79
Application of a theoretic T-wave model to experimentally induced T-wave abnormalities. Circulation (1966) 0.79
Body surface distribution of QRST area. Adv Cardiol (1978) 0.79